← Leaderboards
Marc Elliott Lenburg
Boston University Medical Campus
$9,912,830
Attributed
$25,608,808
Total exposure
12
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2008–25$5M$3.8M$2.5M$1.3M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$29,145,523 · 13
By mechanism
R01$13,942,861 · 6
U01$9,496,879 · 3
U2C$5,705,783 · 4
Top collaborators
- Avrum E Spira26 shared
- Steven M. Dubinett20 shared
- Denise R Aberle14 shared
- David Elashoff14 shared
- Jennifer Ellen Beane4 shared
- William Hsu4 shared
- Stephen C Lam4 shared
- Peter David Pare4 shared
Most similar at Boston University Medical Campus
Same institution · by research overlap
- Avrum E Spira$17,711,843
- Jennifer Ellen Beane$212,128
- Tillie-Louise Hackett$500,789
- Stephen I. Pelton$1,352,372
- Daniel R Brooks$9,273,969
Others in their field
Top investigators on “Malignant Neoplasm Of Lung”
- David Heimbrook · Leidos Biomedical Research, Inc.$349,639,893
- Richard K. Wilson · Washington University$202,666,376
- Walter John Curran · Thomas Jefferson University$94,674,902
- Jan C Buckner · Mayo Clinic Coll Of Medicine, Rochester$61,410,512
- Norman Wolmark · Nsabp Foundation, Inc.$54,610,124
- Leonard Freedman · Leidos Biomedical Research, Inc.$50,919,602
Research focus
Malignant Neoplasm Of LungBostonMolecularUniversitiesCohortGene ExpressionBaseBiological MarkersSamplingInjuryProspectiveSmokerLungNoseImageEpithelialResearch PersonnelDiagnosticEvaluationBioinformaticsMalignant NeoplasmsGenomicsCollaborationsMessenger Rna
Grant awards (49)
The Boston University - UCLA Lung Cancer Biomarker Characterization Center$961,799
U2C · FY2025 · CA · contact PI
Integrating imaging and biopsy-derived molecular markers for the pre-surgical detection of indolent and aggressive early stage lung adenocarcinoma$641,388
R01 · FY2025 · CA · contact PI
Admin Core$366,534
U2C · FY2025 · CA · contact PI
The Boston University - UCLA Lung Cancer Biomarker Characterization Center$913,695
U2C · FY2024 · CA · contact PI
Integrating imaging and biopsy-derived molecular markers for the pre-surgical detection of indolent and aggressive early stage lung adenocarcinoma$607,822
R01 · FY2024 · CA · contact PI
Admin Core$255,597
U2C · FY2024 · CA · contact PI
The Boston University - UCLA Lung Cancer Biomarker Characterization Center$942,572
U2C · FY2023 · CA · contact PI
Integrating imaging and biopsy-derived molecular markers for the pre-surgical detection of indolent and aggressive early stage lung adenocarcinoma$704,857
R01 · FY2023 · CA · contact PI
Admin Core$356,632
U2C · FY2023 · CA · contact PI
The Boston University - UCLA Lung Cancer Biomarker Characterization Center$718,649
U2C · FY2022 · CA · contact PI
Admin Core$67,574
U2C · FY2022 · CA · contact PI
The Boston University-UCLA Lung Cancer Biomarker Development Lab$216,625
U01 · FY2021 · CA · contact PI
Molecular and Imaging Biomarkers for Early Lung Cancer Detection in the Setting of Indeterminate Pulmonary Nodules$181,082
R01 · FY2021 · CA · contact PI
Molecular and Imaging Biomarkers for Early Lung Cancer Detection in the Setting of Indeterminate Pulmonary Nodules$627,805
R01 · FY2020 · CA · contact PI
Integrated Molecular, Cellular, and Imaging Characterization of Screen-Detected Lung Cancer$624,935
U01 · FY2020 · CA
The Boston University-UCLA Lung Cancer Biomarker Development Lab$417,771
U01 · FY2020 · CA · contact PI
Integrated Molecular, Cellular, and Imaging Characterization of Screen-Detected Lung Cancer$798,798
U01 · FY2019 · CA
The Boston University-UCLA Lung Cancer Biomarker Development Lab$516,250
U01 · FY2019 · CA · contact PI
Molecular and Imaging Biomarkers for Early Lung Cancer Detection in the Setting of Indeterminate Pulmonary Nodules$409,210
R01 · FY2019 · CA · contact PI
Data Processing, Analysis, and Modeling Unit$1,122,731
U2C · FY2018 · CA · contact PI
Molecular and Imaging Biomarkers for Early Lung Cancer Detection in the Setting of Indeterminate Pulmonary Nodules$621,526
R01 · FY2018 · CA · contact PI
The Boston University-UCLA Lung Cancer Biomarker Development Lab$518,499
U01 · FY2018 · CA · contact PI
The Boston University-UCLA Lung Cancer Biomarker Development Lab$860,456
U01 · FY2017 · CA
Molecular and Imaging Biomarkers for Early Lung Cancer Detection in the Setting of Indeterminate Pulmonary Nodules$627,525
R01 · FY2017 · CA · contact PI
Molecular and Imaging Biomarkers for Early Lung Cancer Detection in the Setting of Indeterminate Pulmonary Nodules$676,510
R01 · FY2016 · CA
Integrative Omics to Discover Molecular Determinants of COPD$663,066
R01 · FY2016 · HL · contact PI
The Boston University-UCLA Lung Cancer Biomarker Development Lab$565,669
U01 · FY2016 · CA
Integrative Omics to Discover Molecular Determinants of COPD$673,120
R01 · FY2015 · HL · contact PI
The UCLA - Boston University Lung Cancer Biomarker Development Laboratory$185,509
U01 · FY2015 · CA
Integrative Omics to Discover Molecular Determinants of COPD$666,968
R01 · FY2014 · HL · contact PI
The UCLA - Boston University Lung Cancer Biomarker Development Laboratory$598,984
U01 · FY2014 · CA
Molecular biomarkers of airway and lung linking COPD and Lung Cancer$499,578
R01 · FY2014 · CA
The UCLA - Boston University Lung Cancer Biomarker Development Laboratory$781,158
U01 · FY2013 · CA
Integrative Omics to Discover Molecular Determinants of COPD$744,400
R01 · FY2013 · HL · contact PI
The UCLA - Boston University Lung Cancer Biomarker Development Laboratory$593,827
U01 · FY2013 · CA
Molecular biomarkers of airway and lung linking COPD and Lung Cancer$496,897
R01 · FY2013 · CA
Molecular biomarkers of airway and lung linking COPD and lung cancer$99,999
R01 · FY2013 · CA
The UCLA - Boston University Lung Cancer Biomarker Development Laboratory$783,499
U01 · FY2012 · CA
The UCLA - Boston University Lung Cancer Biomarker Development Laboratory$647,222
U01 · FY2012 · CA
Molecular biomarkers of airway and lung linking COPD and Lung Cancer$535,797
R01 · FY2012 · CA
Validation of a Genomic Biomarker of Response to Environmental Tobacco Smoke$487,236
R01 · FY2012 · ES
Linking airway genomics to the pathogenesis and clinical heterogeneity of COPD$692,695
R01 · FY2011 · HL
The UCLA - Boston University Lung Cancer Biomarker Development Laboratory$662,594
U01 · FY2011 · CA
Molecular biomarkers of airway and lung linking COPD and Lung Cancer$562,559
R01 · FY2011 · CA
Validation of a Genomic Biomarker of Response to Environmental Tobacco Smoke$521,116
R01 · FY2011 · ES
The UCLA - Boston University Lung Cancer Biomarker Development Laboratory$725,083
U01 · FY2010 · CA
Linking airway genomics to the pathogenesis and clinical heterogeneity of COPD$703,846
R01 · FY2010 · HL
Linking airway genomics to the pathogenesis and clinical heterogeneity of COPD$737,684
R01 · FY2009 · HL
Linking airway genomics to the pathogenesis and clinical heterogeneity of COPD$760,175
R01 · FY2008 · HL